HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Gillies Selected Research

Blindness (Hysterical Blindness)

12/2022Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry.
11/2022Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry.
5/2022Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion.
5/2022Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry.
4/2022Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry.
2/2022Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry.
1/2022Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry.
1/2022THREE-YEAR TREATMENT OUTCOMES OF AFLIBERCEPT VERSUS RANIBIZUMAB FOR DIABETIC MACULAR EDEMA: Data from the Fight Retinal Blindness! Registry.
11/2021Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis.
5/2020ASSESSING THE ACCURACY OF A LARGE OBSERVATIONAL REGISTRY OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Gillies Research Topics

Disease

18Blindness (Hysterical Blindness)
12/2022 - 01/2019
15Macular Degeneration (Age-Related Maculopathy)
12/2022 - 02/2003
7Macular Edema
11/2022 - 01/2010
6Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 03/2008
5Retinal Vein Occlusion
11/2022 - 06/2010
5Telangiectasis (Telangiectasia)
10/2019 - 12/2010
4Retinal Diseases
11/2022 - 01/2015
3Cataract (Cataracts)
04/2022 - 12/2011
3Choroidal Neovascularization
02/2022 - 03/2013
3Vision Disorders (Hemeralopia)
01/2022 - 04/2005
3Polypoidal Choroidal Vasculopathy
01/2019 - 03/2013
3Retinal Degeneration
01/2019 - 01/2015
2Retinal Detachment (Retinal Detachments)
11/2022 - 04/2005
2Atrophy
11/2021 - 01/2020
2Fibrosis (Cirrhosis)
11/2021 - 12/2020
2Ganglion Cysts (Ganglion)
10/2020 - 01/2018
2Glaucoma
01/2020 - 09/2015
1Peripheral Nervous System Diseases (PNS Diseases)
10/2019
1Multiple Sclerosis
01/2019
1Neuromyelitis Optica (Devic's Disease)
01/2019
1Retinoblastoma (Glioblastoma, Retinal)
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019
1Retinal Neovascularization
01/2016
1Infections
09/2015
1Neuroinflammatory Diseases
01/2015
1Acquired Immunodeficiency Syndrome (AIDS)
03/2013
1Central Serous Chorioretinopathy
03/2013
1Cushing Syndrome
03/2013
1Diabetes Mellitus
05/2012

Drug/Important Bio-Agent (IBA)

29Retinaldehyde (Retinal)IBA
12/2022 - 02/2003
15Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2022 - 09/2014
9Ranibizumab (Lucentis)FDA Link
12/2022 - 09/2013
9afliberceptIBA
12/2022 - 01/2014
6Bevacizumab (Avastin)FDA Link
12/2022 - 01/2014
3Dexamethasone (Maxidex)FDA LinkGeneric
04/2022 - 06/2010
3salicylhydroxamic acid (SHAM)IBA
01/2019 - 06/2010
2MicroRNAs (MicroRNA)IBA
01/2016 - 01/2015
2Fluorescein (Funduscein)FDA LinkGeneric
10/2015 - 03/2013
1Antiglaucoma AgentsIBA
04/2022
1Amino AcidsFDA Link
10/2019
1Serine C-PalmitoyltransferaseIBA
10/2019
1Serine (L-Serine)FDA Link
10/2019
1Transforming Growth Factor beta (TGF-beta)IBA
01/2019
1resazurinIBA
01/2019
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2019
1cadherin 5IBA
01/2019
1Pharmaceutical PreparationsIBA
01/2019
1Immunoglobulin G (IgG)IBA
01/2019
1Neuroprotective AgentsIBA
01/2019
1Simvastatin (Zocor)FDA LinkGeneric
01/2019
1Ciliary Neurotrophic Factor (CNTF)IBA
01/2019
1IronIBA
01/2017
1SteroidsIBA
09/2015
1ArgonIBA
03/2013
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2013
1Macular PigmentIBA
12/2010
1Protein Isoforms (Isoforms)IBA
12/2010
1Glutathione S-Transferase piIBA
12/2010
1Therapeutic UsesIBA
01/2010
1Fenofibrate (CiL)FDA LinkGeneric
03/2008

Therapy/Procedure

6Therapeutics
01/2020 - 09/2014
4Intravitreal Injections
12/2022 - 01/2022
3Injections
01/2019 - 12/2011
2Lasers (Laser)
03/2013 - 05/2012
1Photochemotherapy (Photodynamic Therapy)
01/2019
1Light Coagulation
05/2012
1Drug Therapy (Chemotherapy)
05/2012
1Scleral Buckling
04/2005